Toward cell-replacement therapy for Parkinson's disease: investigating endogenous dopamine neurogenesis in the adult mouse substantia nigra

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Death of a particular type of cell in the brain causes the movement symptoms of Parkinson's disease (PD) (e.g. tremor). This study investigates how these cells are normally replaced, and whether stimulating their replacement can alleviate movement symptoms in an animal model of PD. Fulfillment of these aims will deliver vital information about how we might delay and better treat the movement symptoms of PD.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2014

Funding Scheme: Project Grants

Funding Amount: $577,957.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Central Nervous System

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Parkinson disease | dopamine | neurogenesis | neuronal regeneration | substantia nigra